AEGERION PHARMACEUTICALS INC's ticker is and the CUSIP is 00767EAB8. A total of 16 filers reported holding AEGERION PHARMACEUTICALS INC in Q3 2017. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2017 | $2,686,000 | -52.6% | 3,400 | -51.4% | 0.18% | -62.2% |
| Q1 2017 | $5,670,000 | +30.3% | 7,000 | +16.7% | 0.47% | +14.6% |
| Q4 2016 | $4,350,000 | -47.7% | 6,000 | -27.9% | 0.41% | +1687.0% |
| Q3 2016 | $8,325,000 | +395.5% | 8,325 | -99.7% | 0.02% | -89.6% |
| Q2 2016 | $1,680,000 | – | 3,000,000 | – | 0.22% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Stonepine Capital Management, LLC | 24,200,000 | $15,957,000 | 13.01% |
| Telemetry Investments, L.L.C. | 7,000,000 | $4,616,000 | 2.90% |
| Context Capital Management, LLC | 2,760,000 | $1,826,000 | 1.78% |
| HIGHBRIDGE CAPITAL MANAGEMENT LLC | 67,567,000 | $45,228,000 | 0.72% |
| Tekla Capital Management LLC | 13,000,000 | $8,572,000 | 0.33% |
| OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) | 30,500,000 | $20,035,000,000 | 0.30% |
| Baker Brothers Advisors | 26,517,000 | $17,432,000 | 0.16% |
| FALCON POINT CAPITAL, LLC | 1,500,000 | $937,000 | 0.14% |
| CSS LLC/IL | 1,753,000 | $1,170,000 | 0.06% |
| K2 PRINCIPAL FUND, L.P. | 8,325 | $8,325,000 | 0.02% |